1. Home
  2. EGY vs EVO Comparison

EGY vs EVO Comparison

Compare EGY & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VAALCO Energy Inc.

EGY

VAALCO Energy Inc.

SELL

Current Price

$5.32

Market Cap

657.4M

Sector

Energy

ML Signal

SELL

Logo Evotec SE

EVO

Evotec SE

SELL

Current Price

$1.58

Market Cap

568.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
EGY
EVO
Founded
1985
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
657.4M
568.6M
IPO Year
1996
2007

Fundamental Metrics

Financial Performance
Metric
EGY
EVO
Price
$5.32
$1.58
Analyst Decision
Strong Buy
Buy
Analyst Count
4
3
Target Price
★ $9.45
$4.48
AVG Volume (30 Days)
★ 1.3M
64.6K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
★ 4.68%
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $359,272,000.00
N/A
Revenue This Year
$31.64
N/A
Revenue Next Year
$11.86
$18.90
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$3.36
$1.33
52 Week High
$6.72
$3.87

Technical Indicators

Market Signals
Indicator
EGY
EVO
Relative Strength Index (RSI) 34.04 46.24
Support Level $5.01 $1.50
Resistance Level $5.68 $1.61
Average True Range (ATR) 0.25 0.06
MACD -0.06 0.00
Stochastic Oscillator 27.22 18.75

Price Performance

Historical Comparison
EGY
EVO

About EGY VAALCO Energy Inc.

VAALCO Energy Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil, natural gas, and natural gas liquids (NGLs). It has a diversified, African-focused portfolio of production, development, and exploration assets located in Gabon, Egypt, Cote d'Ivoire, Equatorial Guinea, and Nigeria, which are also considered its reportable operating segments. Maximum revenue is generated from the Gabon segment, which holds working interest in and operates the Etame Marin block, located offshore Gabon. The company derives all of its revenue from crude oil, natural gas, and natural gas liquids sales.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: